Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Tables)

v3.21.1
Stockholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Outstanding Warrants

At December 31, 2020, outstanding warrants to purchase shares of common stock accounted for as equity or liabilities were as follows with an aggregate intrinsic value as of December 31, 2020 of $2,953,726 based on the December 31, 2020 closing share price of $36.47:

 

Shares Underlying            
Outstanding     Exercise     Expiration
Warrants     Price(1)     Date(1)
             
  100,870     $ 7.1875     September 24, 2025
  100,870              

 

(1) The warrants are exercisable at any time and from time to time, in whole or in part, during a period commencing March 24, 2021 and expiring September 24, 2025. The exercise price of the warrants is $7.1875 per share or $6.9718 per share if the warrants are exercised for cash within the first six months of the period in which they are exercisable.